Document Detail

Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
MedLine Citation:
PMID:  10181727     Owner:  NLM     Status:  MEDLINE    
The Food and Drug Administration (FDA) is proposing to amend its regulations governing reports of corrections and removal of medical devices to eliminate the requirement for distributors to make such reports. This proposed rule is a companion document to the direct final rule published elsewhere in this issue of the Federal Register. The amendments are being made to implement provisions of the Federal Food, Drug and Cosmetic Act (the act), as amended by the Food and Drug Administration Modernization Act of 1997 (FDAMA). This companion proposed rule is issued under FDAMA and the act as amended.
Related Documents :
12601387 - Response to novel objects and foraging tasks by common marmoset (callithrix jacchus) fe...
3914237 - Food and drug administration regulation of medical device biotechnology, and food and f...
10180287 - Food labeling: health claims; calcium consumption by adolescents and adults, bone densi...
17995607 - Experimental determination of the dynamics of vacuum impregnation of apples.
1343937 - Anthraquinone pigments production by brown mutant trichoderma viride m-108 under variou...
22159767 - A simple food quality index predicts mortality in elderly taiwanese.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  63     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-09     Completed Date:  1998-09-09     Revised Date:  2000-12-18    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  42300-4     Citation Subset:  H    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Device Approval / legislation & jurisprudence*
Forms and Records Control / legislation & jurisprudence
Industry / legislation & jurisprudence
Product Surveillance, Postmarketing*
United States
United States Food and Drug Administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medicaid and Title IV-E programs; revision to the definition of an unemployed parent--Administration...
Next Document:  Solicitation of information and recommendations for developing OIG compliance program guidance for t...